Indo Us Bio-Tech Ltd
INDOUSIndo Us Bio-Tech Ltd
INDOUS
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 33.74 | 8.29 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.95 | 10.00 | 1.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Indo US Bio-Tech Ltd is a agriculture seed company that is into research and development, production, marketing and sales of all types of Agriculture Seeds.
Peers
Compare with peersGodrej Agrovet Ltd
Gujarat Ambuja Exports Ltd
Sanstar Ltd
Fratelli Vineyards Ltd
Cian Agro Industries & Infrastructure Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.15 | 24.58 | 29.62 | 35.38 | 39.77 | 40.13 | 50.23 | 61.76 | 73.16 | 107.30 | ||||||||||
Raw Materials | 17.78 | 20.12 | 24.16 | 26.71 | 2.81 | 2.46 | 2.18 | 5.27 | 5.88 | 88.62 | ||||||||||
| Power & Fuel Cost | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.07 | 0.07 | 0.14 | 0.18 | |||||||||||
| Employee Cost | 0.38 | 0.36 | 0.38 | 0.27 | 0.35 | 0.34 | 0.48 | 1.19 | 0.92 | |||||||||||
| Selling & Administrative Expenses | 1.49 | 1.52 | 1.54 | 3.40 | 3.04 | 5.59 | 4.61 | 3.68 | 7.61 | |||||||||||
| Operating & Other expenses | -1.13 | 1.24 | 0.57 | 1.51 | 29.57 | 26.10 | 35.77 | 42.08 | 47.44 | |||||||||||
EBITDA | 0.61 | 1.32 | 2.94 | 3.46 | 3.97 | 5.57 | 7.12 | 9.40 | 11.13 | 18.68 | ||||||||||
| Depreciation/Amortization | 0.14 | 0.15 | 0.17 | 0.25 | 0.23 | 0.26 | 0.44 | 0.83 | 0.80 | 0.96 | ||||||||||
| PBIT | 0.47 | 1.17 | 2.77 | 3.21 | 3.74 | 5.31 | 6.68 | 8.57 | 10.33 | 17.72 | ||||||||||
| Interest & Other Items | 0.22 | 0.64 | 0.72 | 0.40 | 0.88 | 1.18 | 1.20 | 1.20 | 1.52 | 1.95 | ||||||||||
| PBT | 0.25 | 0.53 | 2.05 | 2.81 | 2.86 | 4.13 | 5.48 | 7.37 | 8.81 | 15.77 | ||||||||||
| Taxes & Other Items | -0.12 | 0.13 | 0.59 | 0.72 | 0.33 | -0.97 | 0.25 | 0.15 | 0.56 | 0.35 | ||||||||||
| Net Income | 0.37 | 0.40 | 1.46 | 2.09 | 2.53 | 5.10 | 5.23 | 7.22 | 8.25 | 15.42 | ||||||||||
| EPS | 0.28 | 0.30 | 0.66 | 0.92 | 1.74 | 3.50 | 2.04 | 1.88 | 2.74 | 7.69 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indo Us Bio-Tech Ltd | 63.06 | 8.29 | — |
| Godrej Agrovet Ltd | 39.83 | 4.90 | 1.34% |
| Gujarat Ambuja Exports Ltd | 16.91 | 2.11 | 0.27% |
| Sanstar Ltd | 33.46 | 8.80 | — |
Price Comparison
Compare INDOUS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INDOUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateDec 3, 2024
Dividend/Share
₹0.25
Ex DateEx Date
Dec 3, 2024
Cash Dividend
Ex DateEx DateOct 28, 2021
Dividend/Share
₹0.25
Ex DateEx Date
Oct 28, 2021
Indo Us Bio-Tech has fixed 03 December 2024 as record date for payment of interim dividend for FY 2024-25. The payment will be completed on or before 19 December 2024. Powered by Capital Market - Live
Indo US Bio-Tech announced that the Board of Directors of the Company at its meeting held on 21 November 2024, has recommended a Interim dividend of Rs.0.25 per share (i.e.2.5%), subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales22.1715.81 40 OPM %23.1416.45 - PBDT4.632.19 111 PBT4.451.98 125 NP4.361.67 161 Powered by Capital Market - Live
Indo US Bio-Tech has revised the meeting of the Board of Directors which was scheduled to be held on 16 November 2024. The meeting will now be held on 21 November 2024.Powered by Capital Market - Live
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 16 November 2024Powered by Capital Market - Live
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as against Rs 2.37 crore during the previous quarter ended June 2023. Sales rose 29.15% to Rs 24.72 crore in the quarter ended June 2024 as against Rs 19.14 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7219.14 29 OPM %14.9315.62 - PBDT3.392.65 28 PBT3.192.45 30 NP3.172.37 34 Powered by Capital Market - Live
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.64%, vs industry avg of 5.72%
Increasing Market Share
Over the last 5 years, market share increased from 0.17% to 0.2%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 31.6%, vs industry avg of 4.03%